Terms: = Lung cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
96549 results:
1. Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
[TBL] [Abstract] [Full Text] [Related]
2. Structural Racism as a Contributor to lung cancer Incidence and Mortality Rates Among Black Populations in the United States.
Robinson-Oghogho JN; Alcaraz KI; Thorpe RJ
Cancer Control; 2024; 31():10732748241248363. PubMed ID: 38698674
[TBL] [Abstract] [Full Text] [Related]
3. Radicality of mediastinal lymphadenectomy in minimally invasive pulmonary resection: a comparative analysis of uniportal and multiportal thoracoscopic approaches.
Tulinský L; Kepičová M; Ihnát P; Mitták M; Adamica D; Čierna L; Martínek L
Rozhl Chir; 2024; 103(2):48-56. PubMed ID: 38697813
[TBL] [Abstract] [Full Text] [Related]
4. Association of log odds of positive lymph nodes with survival in patients with small cell lung cancer: Results from the SEER database.
Gao T; Chang Y; Yue H
Clinics (Sao Paulo); 2024; 79():100369. PubMed ID: 38696974
[TBL] [Abstract] [Full Text] [Related]
5. lung cancer-specific symptoms and fear of cancer recurrence among recurrence-free non-small cell lung cancer survivors.
Lee G; Ahn A; Lee D; Kim TE; Kong S; Kang D; Kim HK; Shim YM; Cho J
Support Care Cancer; 2024 May; 32(5):322. PubMed ID: 38695959
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis.
Gong S; Li Q; Yu X; Yang S
Front Immunol; 2024; 15():1362537. PubMed ID: 38694505
[TBL] [Abstract] [Full Text] [Related]
7. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
[TBL] [Abstract] [Full Text] [Related]
8. Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice.
Huang X; Pang G; Mao Z; Li B; Teng Z; Yang Y; Qiu Z; Chen X; Wang P
Clin Respir J; 2024 May; 18(5):e13761. PubMed ID: 38693705
[TBL] [Abstract] [Full Text] [Related]
9. Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.
Ferencz B; Török K; Pipek O; Fillinger J; Csende K; Lantos A; Černeková R; Mitták M; Škarda J; Delongová P; Megyesfalvi E; Schelch K; Lang C; Solta A; Boettiger K; Brcic L; Lindenmann J; Rényi-Vámos F; Aigner C; Berta J; Megyesfalvi Z; Döme B
Cancer Immunol Immunother; 2024 May; 73(6):114. PubMed ID: 38693435
[TBL] [Abstract] [Full Text] [Related]
10. Interstitial lung Abnormalities.
Beasley MB
Surg Pathol Clin; 2024 Jun; 17(2):215-225. PubMed ID: 38692806
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract] [Full Text] [Related]
12. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
13. Progression to Lymph Node Metastasis After Spontaneous Regression of Pulmonary Adenocarcinoma Following Biopsy.
Kaira K; Imai H; Mouri A; Yamaguchi OU; Kagamu H
In Vivo; 2024; 38(3):1498-1502. PubMed ID: 38688648
[TBL] [Abstract] [Full Text] [Related]
14. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
15. Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early lung cancer.
Borghetti P; Costantino G; Santoro V; Mataj E; Singh N; Vitali P; Greco D; Volpi G; Sepulcri M; Guida C; Tomasi C; Buglione M; Nardone V
In Vivo; 2024; 38(3):1359-1366. PubMed ID: 38688600
[TBL] [Abstract] [Full Text] [Related]
16. Local therapy combined with anti-PD-1 immunotherapy for advanced lung adenocarcinoma: A case report.
Wu N; Yang X; Zhai Y; Lu W
J Cancer Res Ther; 2024 Apr; 20(2):739-744. PubMed ID: 38687948
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
[TBL] [Abstract] [Full Text] [Related]
18. Microwave ablation combined with percutaneous vertebroplasty for treating painful non-small cell lung cancer with spinal metastases under real-time temperature monitoring.
Wu L; Hu M; Li P; Man Q; Yuan Q; Zhang X; Qiu Y; Chen L; Fan J; Zhang K
J Cancer Res Ther; 2024 Apr; 20(2):540-546. PubMed ID: 38687923
[TBL] [Abstract] [Full Text] [Related]
19. Incidence of thromboembolic events in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Yang M; Cao H; Wang C; Yu C; Sun P
J Cancer Res Ther; 2024 Apr; 20(2):509-521. PubMed ID: 38687920
[TBL] [Abstract] [Full Text] [Related]
20. The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.
Zhang MS; Yeh YC; Huang HN; Lin LW; Huang YL; Wang LC; Yao LJ; Hung TC; Tseng YF; Lee YH; Liao WY; Shih JY; Hsieh MS
PLoS One; 2024; 19(4):e0301120. PubMed ID: 38687753
[TBL] [Abstract] [Full Text] [Related]
[Next]
